LP
NVO

LMR Partners’s Novo Nordisk NVO Stock Holding History

LMR Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-277,400
Closed -$10.2M – 1697
2026
Q1 		$10.2M Buy
277,400
+31,900
+13% +$1.51M 0.02% 416
2025
Q4 		$12.5M Buy
245,500
+162,400
+195% +$8.3M 0.02% 301
2025
Q3 		$4.61M Buy
+83,100
New +$4.86M 0.02% 531
2025
Q1 		– Sell
-120,000
Closed -$10.3M – 1569
2024
Q4 		$10.3M Sell
120,000
-165,900
-58% -$17.9M 0.09% 238
2024
Q3 		$34M Buy
285,900
+58,400
+26% +$7.79M 0.27% 66
2024
Q2 		$32.5M Buy
227,500
+6,600
+3% +$875K 0.27% 72
2024
Q1 		$28.4M Buy
220,900
+205,300
+1,316% +$24.4M 0.29% 67
2023
Q4 		$1.61M Sell
15,600
-183,400
-92% -$18.1M 0.02% 510
2023
Q3 		$18.1M Buy
199,000
+33,400
+20% +$2.94M 0.2% 121
2023
Q2 		$13.4M Buy
+165,600
New +$13.5M 0.15% 157

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

LMR Partners's NVO Position: Q2 2026 in Review

LMR Partners sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 63,871 shares — an estimated $2.35M sold.

LMR Partners first reported a position in NVO in Q2 2022 and held it in 12 quarters. The position peaked at $8.3M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • LMR Partners reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • LMR Partners sold 63,871 Novo Nordisk shares in Q2 2026, an estimated $2.35M.
  • LMR Partners first reported a position in Novo Nordisk in Q2 2022 and held it in 12 quarters.
  • LMR Partners's Novo Nordisk position peaked at $8.3M in Q2 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.